|
Volumn 68, Issue 3, 2014, Pages 204-208
|
Therapeutic modalities of exudative age-related macular degeneration.
a a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AFLIBERCEPT;
ANGIOGENESIS INHIBITOR;
APTAMER;
BEVACIZUMAB;
HYBRID PROTEIN;
MONOCLONAL ANTIBODY;
PEGAPTANIB;
RANIBIZUMAB;
VASCULOTROPIN A;
VASCULOTROPIN RECEPTOR;
DRUG ANTAGONISM;
HUMAN;
IONIZING RADIATION;
LENS IMPLANT;
MULTIMODALITY CANCER THERAPY;
RETINA MACULA DEGENERATION;
REVIEW;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
APTAMERS, NUCLEOTIDE;
COMBINED MODALITY THERAPY;
HUMANS;
LENSES, INTRAOCULAR;
MACULAR DEGENERATION;
RADIATION, IONIZING;
RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR;
RECOMBINANT FUSION PROTEINS;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
|
EID: 84907926986
PISSN: None
EISSN: None
Source Type: Journal
DOI: 10.5455/medarh.2014.68.204-208 Document Type: Review |
Times cited : (10)
|
References (0)
|